Rogers Corporation Press Releases

ROG 
$57.84
*  
0.99
1.68%
Get ROG Alerts
*Delayed - data as of Sep. 19, 2014  -  Find a broker to begin trading ROG now
Exchange: NYSE
Industry: Basic Industries
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

ACCU-CHEK® Aviva Expert, the first and only stand-alone blood glucose meter system with a built-in insulin calculator, is now available
9/16/2014 8:00:00 AM - PR Newswire

Roxgold Intercepts 39.6 Grams Per Tonne Gold Over 4.54 Metres and Discovers New Structure in Drilling at Bagassi South
9/8/2014 7:59:00 AM - PR Newswire

Seragon Pharmaceuticals Inc. Announces Closing of Its Acquisition by Genentech
8/27/2014 4:15:00 PM - GlobeNewswire

Roxgold Reports Financial Results For Second Quarter 2014
8/26/2014 6:45:00 PM - PR Newswire

Harwood Feffer LLP Announces Investigation of Intermune, Inc.
8/25/2014 2:17:00 PM - PR Newswire

Spring Bioscience launches highly sensitive PD-L1 (SP142) antibody, a component of Roche's immunotherapy assay
8/25/2014 10:00:00 AM - PR Newswire

Roche and InterMune Reach Definitive Merger Agreement
8/24/2014 12:00:00 PM - PR Newswire

Full digitization of the anatomic pathology lab is here with the VENTANA System for Primary Diagnosis
8/20/2014 10:00:00 AM - PR Newswire

Roxgold Announces Approval of Environmental and Social Impact Assessment for the Yaramoko Gold Project
8/19/2014 7:00:00 AM - PR Newswire

FDA Approves Genentech’s Avastin Plus Chemotherapy for Treatment of Advanced Cervical Cancer
8/14/2014 3:52:00 PM - Business Wire

Genentech Submits Supplemental Biologics License Application to FDA for Lucentis Indication in Diabetic Retinopathy
8/8/2014 11:30:00 AM - Business Wire

Ventana paves the way for companion diagnostic early phase clinical trials in China to advance patient care
8/5/2014 10:00:00 AM - PR Newswire

Rogers Corporation Reports All-Time Record Quarterly Sales for the Second Quarter of 2014
7/29/2014 4:01:00 PM - Business Wire

Roche focuses on partnering with customers to redefine the value of the laboratory at the AACC 2014 Clinical Lab Expo
7/29/2014 10:44:00 AM - PR Newswire

FDA Grants Genentech’s Avastin Priority Review for Recurrent Platinum-Resistant Ovarian Cancer
7/22/2014 1:11:00 AM - Business Wire

Rogers Corporation Updates Guidance for the Second Quarter 2014 and Invites You to Join its Second Quarter 2014 Conference Call
7/17/2014 4:01:00 PM - Business Wire

FDA Grants Genentech’s Avastin Priority Review for Certain Types of Cervical Cancer
7/15/2014 1:00:00 AM - Business Wire

Genentech’s Investigational Medicine Cobimetinib, Used in Combination with Zelboraf® (Vemurafenib), Helped People with Advanced Melanoma Live Significantly Longer Without Their Disease Worsening
7/14/2014 1:00:00 AM - Business Wire

Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment
7/10/2014 10:00:00 AM - PR Newswire

Rogers Corporation to Present at CJS Securities, Inc. Fourteenth Annual “New Ideas” Summer Conference
7/2/2014 8:59:00 AM - Business Wire

Seragon Pharmaceuticals Announces Acquisition Agreement With Genentech
7/2/2014 1:00:00 AM - GlobeNewswire

Genentech Announces Definitive Agreement to Acquire Seragon Pharmaceuticals
7/2/2014 1:00:00 AM - Business Wire

Roxgold Mandates Société Générale and Credit Suisse for $75 Million Senior Secured Project Financing
6/26/2014 8:47:00 AM - PR Newswire